Core Scientific (NASDAQ:CORZ) Insider Sells $127,800.00 in Stock

Core Scientific, Inc. (NASDAQ:CORZ) insider Todd Duchene sold 10,000 shares of the stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $12.78, for a total transaction of $127,800.00. Following the transaction, the insider owned 1,123,286 shares of the company’s stock, valued at $14,355,595.08. This represents a 0.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Core Scientific Stock Up 3.3%

Shares of CORZ opened at $11.76 on Friday. The firm has a 50 day moving average of $15.68 and a 200 day moving average of $19.48. The company has a market capitalization of $3.78 billion, a P/E ratio of -3.37 and a beta of 5.56. Core Scientific, Inc. has a twelve month low of $10.59 and a twelve month high of $30.46.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.54. The firm had revenue of $232.87 million for the quarter, compared to analyst estimates of $196.54 million. On average, sell-side analysts expect that Core Scientific, Inc. will post -1.36 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Capital One Financial set a $33.00 price objective on Core Scientific in a report on Thursday, July 30th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Core Scientific in a report on Thursday, October 15th. Keefe, Bruyette & Woods raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $25.00 to $28.00 in a research report on Thursday, July 30th. Needham & Company LLC cut their price target on shares of Core Scientific from $35.00 to $28.00 and set a “buy” rating on the stock in a report on Friday. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $36.00 target price on shares of Core Scientific in a report on Thursday, October 15th. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $30.54.

Key Headlines Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Core Scientific reported Q3 2026 earnings of $0.47 per share, versus analysts’ expected loss, while revenue of $232.87 million also exceeded estimates. The results provide a fundamental catalyst for investor optimism. Core Scientific surpasses Q3 earnings and revenue estimates
• Positive Sentiment: Traders bought 143,273 CORZ call options Friday, about 127% above average volume. The surge may reflect increased bullish speculation, though options activity does not guarantee future gains.
• Neutral Sentiment: Needham cut its price target from $35 to $28 but maintained a Buy rating. The lower target tempers the outlook, while the continued Buy rating signals the analyst still sees substantial potential upside relative to the cited $11.76 price.
• Negative Sentiment: Insider Todd Duchene sold 10,000 shares for $127,800, reducing his holdings by 0.88%. The sale is a modest cautionary signal, although he retained more than 1.1 million shares. Core Scientific insider sale

Institutional Investors Weigh In On Core Scientific

Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in Core Scientific in the second quarter valued at $719,649,000. Apollo Management Holdings L.P. acquired a new position in shares of Core Scientific during the second quarter valued at $115,671,000. Avala Global LP acquired a new position in shares of Core Scientific during the 2nd quarter worth about $101,729,000. Bank of America Corp DE acquired a new position in Core Scientific in the second quarter valued at about $93,668,000. Finally, Squarepoint Ops LLC increased its position in Core Scientific by 64.1% in the 2nd quarter. Squarepoint Ops LLC now owns 2,686,177 shares of the company’s stock valued at $68,739,000 after buying an additional 1,049,678 shares in the last quarter.

About Core Scientific

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers for high-performance computing. The company has historically focused on bitcoin mining, using specialized computing equipment and supporting infrastructure to validate transactions on the Bitcoin network. It also provides hosting and infrastructure services for other digital asset miners.

Core Scientific is expanding its business toward hosting high-performance computing and artificial intelligence workloads.